͵͵

News

Astrocyte cells in the fruit fly brain are an on-off switch

Sarah DeGenova Ackerman
By Sarah DeGenova Ackerman
May 9, 2021

Neuroplasticity — the ability of neurons to — can be turned off and on by the cells that surround neurons in the brain, on fruit flies that I co-authored.

Astrocyte-cells-445x219.jpg
Sarah DeGenova Ackerman,
The colors in this microscope photo of a fruit fly brain show different types of neurons
and the cells that surround them in the brain.

As fruit fly larvae age, their neurons shift from a highly adaptable state to a stable state and lose their ability to change. During this process, support cells in the brain – called astrocytes — that send and receive electrical information. When my team removed the astrocytes, the neurons in the fruit fly larvae remained plastic longer, hinting that somehow astrocytes suppress a neuron's ability to change. We then discovered two specific proteins that regulate neuroplasticity.

Why it matters

The human brain is made up of billions of neurons that form complex connections with one another. Flexibility at these connections is a , but things can go wrong if it isn't tightly regulated. For example, in people, too much plasticity at the wrong time is linked to brain disorders such as and . Additionally, reduced levels of the two neuroplasticity-controlling proteins we identified are linked to increased susceptibility to and .

Similarly, in our fruit flies, removing the cellular brakes on plasticity permanently impaired their crawling behavior. While fruit flies are of course different from humans, their brains work in very similar ways to the human brain and can offer valuable insight.

Fruit-flies-754x488.jpg
Sarah DeGenova Ackerman,
As fruit flies develop, special cells surround their neurons and seem to halt neuroplasticity.

One obvious benefit of discovering the effect of these proteins is the potential to treat some neurological diseases. But since a neuron's flexibility is closely tied to learning and memory, in theory, researchers might be able to in a controlled way to . This could, for example, allow people to more easily learn a new language or musical instrument.

How we did the work

focused our experiments on a specific type of neurons called motor neurons. These control movements like and in fruit flies. To figure out how astrocytes controlled neuroplasticity, we used genetic tools to turn off specific proteins in the astrocytes one by one and then measured the effect on motor neuron structure. We found that astrocytes and motor neurons communicate with one another using a specific pair of proteins called neuroligins and neurexins. These proteins essentially function as an off button for .

What still isn't known

My team discovered that two proteins can control neuroplasticity, but we don't know how these cues from astrocytes cause neurons to lose their ability to change.

Additionally, researchers still know very little about why neuroplasticity is so strong in younger animals and . In our study, we showed that prolonging plasticity beyond development can sometimes be , but we don't yet know why that is, either.

Fruit-flies-brain-445x254.jpg
Sarah DeGenova Ackerman
This is a caption.In this image showing a developing fruit fly brain on the right
and the attached nerve cord on the left, the astrocytes are labeled in different
colors showing their wide distribution among neurons.

What's next

I want to explore why longer periods of neuroplasticity can be harmful. Fruit flies are great study organisms for this research because it is very easy to . In my team's next project, we hope to determine how changes in neuroplasticity during development can lead to long–term changes in behavior.

There is so much more work to be done, but our research is a first step toward treatments that use astrocytes to influence how neurons change in the mature brain. If researchers can understand the basic mechanisms that control neuroplasticity, they will be one step closer to developing therapies to treat a variety of neurological disorders.

This article is republished from under a Creative Commons license. Read the .

The Conversation

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Sarah DeGenova Ackerman
Sarah DeGenova Ackerman

Sarah DeGenova Ackerman is a postdoctoral fellow at the University of Oregon Institute of Neuroscience and Howard Hughes Medical Institute.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Guiding grocery carts to shape healthy habits
Award

Guiding grocery carts to shape healthy habits

Nov. 21, 2024

Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Quantifying how proteins in microbe and host interact
Journal News

Quantifying how proteins in microbe and host interact

Nov. 20, 2024

“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.

Leading the charge for gender equity
Award

Leading the charge for gender equity

Nov. 19, 2024

Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.

CRISPR gene editing: Moving closer to home
News

CRISPR gene editing: Moving closer to home

Nov. 17, 2024

With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.

Finding a missing piece for neurodegenerative disease research
News

Finding a missing piece for neurodegenerative disease research

Nov. 16, 2024

Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.

From the journals: JLR
Journal News

From the journals: JLR

Nov. 15, 2024

Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.